XOMA【XOMAP】株式ニュース

名称	銘柄コード	市場	種別
XOMA Corporation	XOMAP	NASDAQ	Preference Share

	前日比	前日比 %	現在値	時刻
	0.00	0.00%	25.10	00:06:14

始値	安値	高値	終値	前日終値
				25.10

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/18	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/16	20:31	EDGAR2	Form 8-K - Current report
2024/5/14	20:30	GLOBE	XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect..
2024/5/09	20:45	EDGAR2	Form 8-K - Current report
2024/5/09	20:35	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/09	20:30	GLOBE	XOMA Reports First Quarter 2024 Financial Results and..
2024/4/30	20:30	GLOBE	XOMA Adds Economic Interests in Three First-in-Category..
2024/4/25	20:30	GLOBE	XOMA Earns $9 Million Milestone as FDA Grants Accelerated..
2024/4/03	22:00	GLOBE	XOMA Corporation Announces Closing of Tender Offer
2024/3/21	20:30	GLOBE	XOMA Declares Quarterly Preferred Stock Dividends
2024/3/20	05:05	GLOBE	XOMA Announces Calculation of Additional Price Per Share and..
2024/3/11	19:56	EDGAR2	Form S-4 - Registration of securities, business combinations
2024/3/09	06:34	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2024/3/08	21:39	EDGAR2	Form 8-K - Current report
2024/3/08	21:30	GLOBE	XOMA Reports Fourth Quarter and Full Year 2023 Financial..
2024/3/05	07:24	EDGAR2	Form SC TO-T - Tender offer statement by Third Party
2024/2/28	21:30	GLOBE	XOMA to Present at Upcoming Investor Conferences in March
2024/2/16	23:08	EDGAR2	Form 8-K - Current report
2024/2/16	22:00	GLOBE	XOMA Enters into Agreement to Acquire Kinnate Biopharma for..
2024/1/18	22:30	GLOBE	XOMA Expands its Commercial Royalty and Milestone Portfolio..
2024/1/17	07:22	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2024/1/12	06:31	EDGAR2	Form 8-K - Current report
2024/1/12	06:05	GLOBE	FDA Acceptance of Zevra’s Arimoclomol NDA Filing for..
2024/1/11	06:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/08	21:30	GLOBE	XOMA Names Owen Hughes as Chief Executive Officer and..
2024/1/02	21:46	EDGAR2	Form 8-K - Current report
2024/1/02	21:30	GLOBE	XOMA Announces Stock Repurchase Program of up to $50 Million
2023/12/20	21:30	GLOBE	XOMA Declares Quarterly Preferred Stock Dividends
2023/12/19	21:40	EDGAR2	Form 8-K - Current report
2023/12/19	21:30	GLOBE	XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse..
2023/11/07	21:40	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07	21:40	EDGAR2	Form 8-K - Current report
2023/11/07	21:30	GLOBE	XOMA Reports Third Quarter 2023 Financial Results and..
2023/10/31	20:35	EDGAR2	Form 8-K - Current report
2023/10/31	20:30	GLOBE	XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day..
2023/10/28	06:06	EDGAR2	Form 8-K - Current report
2023/10/05	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/05	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/28	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/25	20:30	GLOBE	XOMA Declares Quarterly Preferred Stock Dividends
2023/9/12	05:10	EDGAR2	Form 8-K - Current report
2023/9/06	20:30	GLOBE	XOMA to Present at H.C. Wainwright 25th Annual Global..
2023/8/26	06:09	EDGAR2	Form 8-K - Current report
2023/8/08	20:41	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/08	20:35	EDGAR2	Form 8-K - Current report